Disease | multiple myeloma |
Symptom | C0022658|renal disease |
Sentences | 8 |
PubMedID- 21701535 | The renal diseases most frequently associated with myeloma include amyloidosis, monoclonal immunoglobulin deposition disease, and cast nephropathy. |
PubMedID- 19953253 | Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. |
PubMedID- 20037169 | Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an era-edta registry study. |
PubMedID- 21217460 | Background: specific tolerance after combined kidney and bone marrow transplantation for multiple myeloma with end-stage renal disease through mixed lymphohematopoietic chimerism has been achieved, as evidenced by prolonged normal renal function without ongoing immunosuppression. |
PubMedID- 25976156 | Fatal case of herbaspirillum seropedicae bacteremia secondary to pneumonia in an end-stage renal disease patient with multiple myeloma. |
PubMedID- 20671999 | Cast nephropathy is the most frequent cause of paraprotein renal disease in patients with myeloma, accounting for two-thirds of those with this disease 8. |
PubMedID- 25838654 | The renal diseases most frequently associated with myeloma include cast nephropathy (cn), amyloidosis and monoclonal immunoglobulin deposition disease. |
PubMedID- 23051666 | It is therefore timely to reappraise the potential role of renal transplantation in end-stage renal disease due to multiple myeloma and other pcd. |
Page: 1